Annual Working Capital
$58.91 M
+$2.19 M+3.86%
December 31, 2023
Summary
- As of February 8, 2025, LPTX annual working capital is $58.91 million, with the most recent change of +$2.19 million (+3.86%) on December 31, 2023.
- During the last 3 years, LPTX annual working capital has risen by +$14.01 million (+31.20%).
- LPTX annual working capital is now -44.88% below its all-time high of $106.89 million, reached on December 31, 2021.
Performance
LPTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$47.72 M
-$16.27 M-25.43%
September 30, 2024
Summary
- As of February 8, 2025, LPTX quarterly working capital is $47.72 million, with the most recent change of -$16.27 million (-25.43%) on September 30, 2024.
- Over the past year, LPTX quarterly working capital has dropped by -$11.19 million (-19.00%).
- LPTX quarterly working capital is now -58.08% below its all-time high of $113.84 million, reached on September 30, 2021.
Performance
LPTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
LPTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.9% | -19.0% |
| 3 y3 years | +31.2% | -49.4% |
| 5 y5 years | +441.9% | -49.4% |
LPTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.9% | +3.9% | -55.4% | +4.3% |
| 5 y | 5-year | -44.9% | +1487.8% | -58.1% | +1224.1% |
| alltime | all time | -44.9% | +283.4% | -58.1% | +248.5% |
Leap Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $47.72 M(-25.4%) |
| Jun 2024 | - | $63.99 M(+39.9%) |
| Mar 2024 | - | $45.75 M(-22.3%) |
| Dec 2023 | $58.91 M(+3.9%) | $58.91 M(-16.7%) |
| Sep 2023 | - | $70.72 M(-13.9%) |
| Jun 2023 | - | $82.12 M(-13.0%) |
| Mar 2023 | - | $94.39 M(+66.4%) |
| Dec 2022 | $56.73 M(-46.9%) | $56.73 M(-16.8%) |
| Sep 2022 | - | $68.22 M(-16.8%) |
| Jun 2022 | - | $82.03 M(-16.0%) |
| Mar 2022 | - | $97.60 M(-8.7%) |
| Dec 2021 | $106.89 M(+138.0%) | $106.89 M(-6.1%) |
| Sep 2021 | - | $113.84 M(+307.1%) |
| Jun 2021 | - | $27.96 M(-23.1%) |
| Mar 2021 | - | $36.39 M(-19.0%) |
| Dec 2020 | $44.90 M(-1157.8%) | $44.90 M(-13.1%) |
| Sep 2020 | - | $51.69 M(-11.6%) |
| Jun 2020 | - | $58.44 M(+248.2%) |
| Mar 2020 | - | $16.79 M(-495.4%) |
| Dec 2019 | -$4.25 M | -$4.25 M(-237.4%) |
| Sep 2019 | - | $3.09 M(-63.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $8.34 M(-42.6%) |
| Mar 2019 | - | $14.53 M(+33.6%) |
| Dec 2018 | $10.87 M(-49.6%) | $10.87 M(-40.7%) |
| Sep 2018 | - | $18.33 M(-29.6%) |
| Jun 2018 | - | $26.02 M(-15.6%) |
| Mar 2018 | - | $30.82 M(+42.8%) |
| Dec 2017 | $21.57 M(-167.2%) | $21.57 M(+105.3%) |
| Sep 2017 | - | $10.51 M(-35.7%) |
| Jun 2017 | - | $16.35 M(-27.9%) |
| Mar 2017 | - | $22.67 M(-170.6%) |
| Dec 2016 | -$32.13 M(+521.0%) | -$32.13 M(-228.3%) |
| Jun 2016 | - | $25.04 M(-584.0%) |
| Dec 2015 | -$5.17 M(-111.7%) | -$5.17 M(-118.4%) |
| Sep 2015 | - | $28.05 M(-16.1%) |
| Jun 2015 | - | $33.45 M(-14.9%) |
| Mar 2015 | - | $39.32 M(-11.1%) |
| Dec 2014 | $44.23 M(+151.4%) | $44.23 M(-15.7%) |
| Sep 2014 | - | $52.49 M(+395.8%) |
| Jun 2014 | - | $10.59 M(-26.4%) |
| Mar 2014 | - | $14.39 M(-18.2%) |
| Dec 2013 | $17.59 M(+21.2%) | $17.59 M |
| Dec 2012 | $14.51 M | - |
FAQ
- What is Leap Therapeutics annual working capital?
- What is the all time high annual working capital for Leap Therapeutics?
- What is Leap Therapeutics annual working capital year-on-year change?
- What is Leap Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Leap Therapeutics?
- What is Leap Therapeutics quarterly working capital year-on-year change?
What is Leap Therapeutics annual working capital?
The current annual working capital of LPTX is $58.91 M
What is the all time high annual working capital for Leap Therapeutics?
Leap Therapeutics all-time high annual working capital is $106.89 M
What is Leap Therapeutics annual working capital year-on-year change?
Over the past year, LPTX annual working capital has changed by +$2.19 M (+3.86%)
What is Leap Therapeutics quarterly working capital?
The current quarterly working capital of LPTX is $47.72 M
What is the all time high quarterly working capital for Leap Therapeutics?
Leap Therapeutics all-time high quarterly working capital is $113.84 M
What is Leap Therapeutics quarterly working capital year-on-year change?
Over the past year, LPTX quarterly working capital has changed by -$11.19 M (-19.00%)